Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iXCells Biotechnologies provides advanced preclinical drug discovery solutions using primary cells and induced pluripotent stem cell-derived models. Their platforms enable custom disease modeling—including patient-specific mutations—using genome editing technologies like CRISPR-Cas9. The company supports academic and industry partners in early-stage research but does not have clinical trial results as it operates primarily as a CRO/service provider[1][2][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iXCells Biotechnologies.